Howe & Rusling’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-90,558
Closed -$3.14M 389
2023
Q4
$3.14M Sell
90,558
-22,084
-20% -$762K 0.33% 78
2023
Q3
$4.08M Buy
112,642
+32,606
+41% +$1.21M 0.48% 65
2023
Q2
$3.01M Buy
+80,036
New +$3.22M 0.34% 72
2020
Q4
Sell
-320
Closed -$12K 959
2020
Q3
$12K Buy
+320
New +$12.6K ﹤0.01% 410

Other funds holding G

Howe & Rusling's G Position: Q1 2024 in Review

Howe & Rusling sold out of Genpact (G) in Q1 2024, closing a stake of 90,558 shares — an estimated $3.14M sold.

Howe & Rusling first reported a position in G in Q3 2020 and held it in 4 quarters. The position peaked at $4.08M in Q3 2023. 364 funds tracked by Wall St. Rank hold G as of Q1 2024.

  • Howe & Rusling reported no remaining Genpact position as of Q1 2024 after selling out during the quarter.
  • Howe & Rusling sold 90,558 Genpact shares in Q1 2024, an estimated $3.14M.
  • Howe & Rusling first reported a position in Genpact in Q3 2020 and held it in 4 quarters.
  • Howe & Rusling's Genpact position peaked at $4.08M in Q3 2023.
  • 364 funds tracked by Wall St. Rank held Genpact as of Q1 2024.

Based on Howe & Rusling's 13F filing for Q1 2024, filed 15 May 2024.